1. Home
  2. BLZE vs ORKA Comparison

BLZE vs ORKA Comparison

Compare BLZE & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLZE
  • ORKA
  • Stock Information
  • Founded
  • BLZE 2007
  • ORKA 2004
  • Country
  • BLZE United States
  • ORKA United States
  • Employees
  • BLZE N/A
  • ORKA N/A
  • Industry
  • BLZE Computer Software: Prepackaged Software
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • BLZE Technology
  • ORKA Health Care
  • Exchange
  • BLZE Nasdaq
  • ORKA Nasdaq
  • Market Cap
  • BLZE 326.5M
  • ORKA 354.2M
  • IPO Year
  • BLZE 2021
  • ORKA N/A
  • Fundamental
  • Price
  • BLZE $5.36
  • ORKA $11.80
  • Analyst Decision
  • BLZE Strong Buy
  • ORKA Strong Buy
  • Analyst Count
  • BLZE 7
  • ORKA 8
  • Target Price
  • BLZE $10.29
  • ORKA $39.71
  • AVG Volume (30 Days)
  • BLZE 386.9K
  • ORKA 325.7K
  • Earning Date
  • BLZE 08-07-2025
  • ORKA 08-15-2025
  • Dividend Yield
  • BLZE N/A
  • ORKA N/A
  • EPS Growth
  • BLZE N/A
  • ORKA N/A
  • EPS
  • BLZE N/A
  • ORKA N/A
  • Revenue
  • BLZE $132,273,000.00
  • ORKA N/A
  • Revenue This Year
  • BLZE $16.08
  • ORKA N/A
  • Revenue Next Year
  • BLZE $13.97
  • ORKA N/A
  • P/E Ratio
  • BLZE N/A
  • ORKA N/A
  • Revenue Growth
  • BLZE 21.81
  • ORKA N/A
  • 52 Week Low
  • BLZE $3.94
  • ORKA $5.49
  • 52 Week High
  • BLZE $8.08
  • ORKA $52.32
  • Technical
  • Relative Strength Index (RSI)
  • BLZE 49.98
  • ORKA N/A
  • Support Level
  • BLZE $5.29
  • ORKA N/A
  • Resistance Level
  • BLZE $5.60
  • ORKA N/A
  • Average True Range (ATR)
  • BLZE 0.22
  • ORKA 0.00
  • MACD
  • BLZE 0.00
  • ORKA 0.00
  • Stochastic Oscillator
  • BLZE 59.82
  • ORKA 0.00

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

Share on Social Networks: